| 16.98 0.68 (4.17%) | 04-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.6 | 1-year : | 21.72 |
| Resists | First : | 17.64 | Second : | 18.6 |
| Pivot price | 17.13  |
|||
| Supports | First : | 16.1 | Second : | 13.39 |
| MAs | MA(5) : | 16.78 |
MA(20) : | 17.33 |
| MA(100) : | 22.39 |
MA(250) : | 22.1 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 17.9 |
D(3) : | 19.7 |
| RSI | RSI(14): 40.9 |
|||
| 52-week | High : | 28.75 | Low : | 16.1 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PGNY ] has closed above bottom band by 42.8%. Bollinger Bands are 51.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 17.01 - 17.12 | 17.12 - 17.21 |
| Low: | 15.92 - 16.04 | 16.04 - 16.15 |
| Close: | 16.79 - 16.97 | 16.97 - 17.14 |
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Mon, 13 Apr 2026
Progyny Inc (PGNY) Shares Surge 4.2% -- What GF Score of 88 Tells Investors - GuruFocus
Wed, 01 Apr 2026
PGNY SEC Filings - Progyny, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Wed, 01 Apr 2026
From 5 employers to 600: Progyny marks 10 years in family care - Stock Titan
Fri, 27 Mar 2026
Vanguard realignment: Progyny (PGNY) Schedule 13G/A shows 0 shares - Stock Titan
Thu, 05 Mar 2026
Is Progyny (PGNY) Using Buybacks and Employee Stock Plans to Recast Its Growth Story? - Yahoo Finance
Wed, 04 Mar 2026
Progyny: Transitional Headwinds Hide An Undervalued Platform (NASDAQ:PGNY) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 82 (M) |
| Shares Float | 75 (M) |
| Held by Insiders | 8.3 (%) |
| Held by Institutions | 107.5 (%) |
| Shares Short | 5,630 (K) |
| Shares Short P.Month | 4,020 (K) |
| EPS | 0.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.23 |
| Profit Margin | 4.5 % |
| Operating Margin | 7.1 % |
| Return on Assets (ttm) | 8.6 % |
| Return on Equity (ttm) | 12.4 % |
| Qtrly Rev. Growth | 6.6 % |
| Gross Profit (p.s.) | 3.71 |
| Sales Per Share | 15.75 |
| EBITDA (p.s.) | 1.19 |
| Qtrly Earnings Growth | 20.6 % |
| Operating Cash Flow | 210 (M) |
| Levered Free Cash Flow | 213 (M) |
| PE Ratio | 26.12 |
| PEG Ratio | 0 |
| Price to Book value | 2.72 |
| Price to Sales | 1.07 |
| Price to Cash Flow | 6.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|